Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies.

MLA

Arase, Noriko, et al. “Cell Surface-Expressed Ro52/IgG/HLA-DR Complex Is Targeted by Autoantibodies in Patients with Inflammatory Myopathies.” Journal of Autoimmunity, vol. 126, Jan. 2022, p. 102774. EBSCOhost, https://doi.org/10.1016/j.jaut.2021.102774.

APA

Arase, N., Tsuji, H., Takamatsu, H., Jin, H., Konaka, H., Hamaguchi, Y., Tonomura, K., Kotobuki, Y., Ueda-Hayakawa, I., Matsuoka, S., Hirano, T., Yorifuji, H., Murota, H., Ohmura, K., Nakashima, R., Sato, T., Kumanogoh, A., Katayama, I., Arase, H., & Fujimoto, M. (2022). Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies. Journal of Autoimmunity, 126, 102774. https://doi.org/10.1016/j.jaut.2021.102774

Chicago

Arase, Noriko, Hideaki Tsuji, Hyota Takamatsu, Hui Jin, Hachiro Konaka, Yasuhito Hamaguchi, Kyoko Tonomura, et al. 2022. “Cell Surface-Expressed Ro52/IgG/HLA-DR Complex Is Targeted by Autoantibodies in Patients with Inflammatory Myopathies.” Journal of Autoimmunity 126 (January): 102774. doi:10.1016/j.jaut.2021.102774.